+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 9m4t | ||||||
---|---|---|---|---|---|---|---|
タイトル | CryoEM structure of the alpha1AAR complex with silodosin | ||||||
![]() | Alpha-1A adrenergic receptor | ||||||
![]() | MEMBRANE PROTEIN / GPCR / Alpha1AAR / Silodosin | ||||||
機能・相同性 | ![]() negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure / alpha1-adrenergic receptor activity / norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure / positive regulation of heart rate by epinephrine-norepinephrine / positive regulation of the force of heart contraction by epinephrine-norepinephrine / pilomotor reflex / phospholipase C-activating adrenergic receptor signaling pathway / neuron-glial cell signaling / cell growth involved in cardiac muscle cell development / positive regulation of action potential ...negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure / alpha1-adrenergic receptor activity / norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure / positive regulation of heart rate by epinephrine-norepinephrine / positive regulation of the force of heart contraction by epinephrine-norepinephrine / pilomotor reflex / phospholipase C-activating adrenergic receptor signaling pathway / neuron-glial cell signaling / cell growth involved in cardiac muscle cell development / positive regulation of action potential / positive regulation of smooth muscle contraction / adult heart development / Adrenoceptors / positive regulation of cardiac muscle hypertrophy / smooth muscle contraction / adenylate cyclase-activating adrenergic receptor signaling pathway / response to hormone / positive regulation of vasoconstriction / positive regulation of cardiac muscle contraction / negative regulation of autophagy / positive regulation of synaptic transmission, GABAergic / caveola / MAPK cascade / G alpha (12/13) signalling events / cell-cell signaling / positive regulation of cytosolic calcium ion concentration / phospholipase C-activating G protein-coupled receptor signaling pathway / nuclear membrane / G alpha (q) signalling events / positive regulation of ERK1 and ERK2 cascade / positive regulation of MAPK cascade / intracellular signal transduction / G protein-coupled receptor signaling pathway / protein heterodimerization activity / response to xenobiotic stimulus / negative regulation of cell population proliferation / intracellular membrane-bounded organelle / apoptotic process / signal transduction / nucleoplasm / nucleus / plasma membrane / cytosol / cytoplasm 類似検索 - 分子機能 | ||||||
生物種 | ![]() | ||||||
手法 | 電子顕微鏡法 / 単粒子再構成法 / クライオ電子顕微鏡法 / 解像度: 3.19 Å | ||||||
![]() | Liu, S.S. / Guo, Q. / Wang, D.D. / Tao, Y.Y. / Jiao, H.Z. | ||||||
資金援助 | ![]()
| ||||||
![]() | ![]() タイトル: Molecular mechanism of antagonists recognition and regulation of the α- adrenoceptor. (α-Adrenoceptor Antagonist Recognition). 著者: Sisi Liu / Haizhan Jiao / Yuyong Tao / Dandan Wang / Qiong Guo / ![]() 要旨: The α-adrenoceptor (αAR) is a critically important class of G protein-coupled receptors (GPCRs), comprising three subtypes: αAR, αAR, and αAR. Currently, drugs targeting αAR have been used in ...The α-adrenoceptor (αAR) is a critically important class of G protein-coupled receptors (GPCRs), comprising three subtypes: αAR, αAR, and αAR. Currently, drugs targeting αAR have been used in the treatment of various diseases. Notably, antagonists of αAR play a pivotal role in the management of benign prostatic hyperplasia (BPH). In recent years, researchers have developed selective antagonists for the αAR subtype that have a minimal impact on blood pressure for the treatment of BPH. However, these agents still exhibit certain side effects, necessitating the continuous development of new medications to mitigate adverse reactions while achieving more precise regulation. We report the cryo-EM structures of the αAR selective antagonist doxazosin and the αAR subtype selective antagonist silodosin in complex with αAR, demonstrating that M292 and V185 are key residues that confer subtype selectivity to silodosin. Additionally, modifications to αAR enhanced silodosin's inhibitory efficacy against αAR. These findings deepen our understanding of the recognition patterns of αAR antagonists, revealing the molecular principles underlying the selective binding of silodosin to αAR and promoting further research and development of subtype selective drugs targeting αAR. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 105.8 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 表示 | ![]() | |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
---|
-関連構造データ
関連構造データ | ![]() 63629MC ![]() 9m4qC M: このデータのモデリングに利用したマップデータ C: 同じ文献を引用 ( |
---|---|
類似構造データ | 類似検索 - 機能・相同性 ![]() |
-
リンク
-
集合体
登録構造単位 | ![]()
|
---|---|
1 |
|
-
要素
#1: タンパク質 | 分子量: 35792.500 Da / 分子数: 1 / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() ![]() |
---|---|
#2: 化合物 | ChemComp-A1EMV / 分子量: 495.534 Da / 分子数: 1 / 由来タイプ: 合成 / 式: C25H32F3N3O4 |
研究の焦点であるリガンドがあるか | N |
Has protein modification | Y |
-実験情報
-実験
実験 | 手法: 電子顕微鏡法 |
---|---|
EM実験 | 試料の集合状態: PARTICLE / 3次元再構成法: 単粒子再構成法 |
-
試料調製
構成要素 | 名称: CryoEM structure of the the alpha1AAR complex with silodosin タイプ: COMPLEX / Entity ID: #1 / 由来: RECOMBINANT |
---|---|
分子量 | 実験値: NO |
由来(天然) | 生物種: ![]() |
由来(組換発現) | 生物種: ![]() |
緩衝液 | pH: 7.4 |
試料 | 包埋: NO / シャドウイング: NO / 染色: NO / 凍結: YES |
急速凍結 | 凍結剤: ETHANE |
-
電子顕微鏡撮影
実験機器 | ![]() モデル: Titan Krios / 画像提供: FEI Company |
---|---|
顕微鏡 | モデル: TFS KRIOS |
電子銃 | 電子線源: ![]() |
電子レンズ | モード: BRIGHT FIELD / 最大 デフォーカス(公称値): 2300 nm / 最小 デフォーカス(公称値): 1700 nm |
撮影 | 電子線照射量: 50 e/Å2 / フィルム・検出器のモデル: GATAN K3 (6k x 4k) |
-
解析
CTF補正 | タイプ: NONE |
---|---|
3次元再構成 | 解像度: 3.19 Å / 解像度の算出法: FSC 0.143 CUT-OFF / 粒子像の数: 3759439 / 対称性のタイプ: POINT |